AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹529 Cr | ₹1,157 Cr | ₹785 Cr | ₹792 Cr | ₹562 Cr |
What is the latest Cash Flow from Operating Activities ratio of AJANTA PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹529 Cr |
| Mar2025 | ₹1,157 Cr |
| Mar2024 | ₹785 Cr |
| Mar2023 | ₹792 Cr |
| Mar2022 | ₹562 Cr |
How is Cash Flow from Operating Activities of AJANTA PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹529 Cr | -54.27 | |
| Mar2025 | ₹1,157 Cr | 47.40 | |
| Mar2024 | ₹785 Cr | -0.89 | |
| Mar2023 | ₹792 Cr | 41.02 | |
| Mar2022 | ₹562 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹41,801.5 Cr | 2.9% | 14% | 33.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 2.9% |
14% |
33.5% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses